SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABR Information Services (ABRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Mac who wrote (109)3/13/1998 7:48:00 PM
From: Russ Parker  Read Replies (1) of 156
 
True, growth has decelerated. But that doesn't neccesarily mean the stock has to tank. Not many companies maintain triple digit growth. If they maintain 30-40% growth over the next 3 to five years, then it's PE is not out of line with alot of other software/service companies. Saying the stock will possibly go down to 10 makes it sound like this is a company with severe problems. I do think the valuation is a little rich based on earnings estimates. On the positive side, they have been beating estimates. I don't think it's the greatest stock for short term traders. My broker specializes in companies that have long term earnings growth of 20% or more. I've seen stocks stay dormant for a year, then all of the sudden they pick up steam. The key is will they maintain 30% plus growth for the next 3 to five years. The party is not over just because they are not growing at triple digit rates. I don't think the Ascend comparison was good either.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News